日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

CDK4/6 Inhibition With Lerociclib is a Potential Therapeutic Strategy for the Treatment of Pediatric Sarcomas.

使用 Lerociclib 抑制 CDK4/6 是治疗儿童肉瘤的潜在治疗策略

Julson Janet R, Horton Sara C, Quinn Colin H, Beierle Andee M, Bownes Laura V, Stewart Jerry E, Aye Jamie, Yoon Karina J, Beierle Elizabeth A

PIM Kinase Inhibition Sensitizes Neuroblastoma to Doxorubicin.

PIM激酶抑制剂可增强神经母细胞瘤对阿霉素的敏感性

Julson Janet R, Quinn Colin H, Nazam Nazia, Bownes Laura V, Stewart Jerry E, Beierle Elizabeth A

Metastatic human hepatoblastoma cells exhibit enhanced tumorigenicity, invasiveness and a stem cell-like phenotype

转移性人肝母细胞瘤细胞表现出增强的致瘤性、侵袭性和干细胞样表型

Marayati, Raoud; Julson, Janet R; Bownes, Laura V; Quinn, Colin H; Hutchins, Sara C; Williams, Adele P; Markert, Hooper R; Beierle, Andee M; Stewart, Jerry E; Hjelmeland, Anita B; Mroczek-Musulman, Elizabeth; Beierle, Elizabeth A

9-cis-UAB30, a novel rexinoid agonist, decreases tumorigenicity and cancer cell stemness of human neuroblastoma patient-derived xenografts

9-顺式-UAB30 是一种新型雷西诺类激动剂,可降低人神经母细胞瘤患者来源异种移植瘤的致瘤性和癌细胞干性。

Marayati, Raoud; Bownes, Laura V; Stafman, Laura L; Williams, Adele P; Quinn, Colin H; Atigadda, Venkatram; Aye, Jamie M; Stewart, Jerry E; Yoon, Karina J; Beierle, Elizabeth A

Novel second-generation rexinoid induces growth arrest and reduces cancer cell stemness in human neuroblastoma patient-derived xenografts

新型第二代雷西诺类药物可诱导人类神经母细胞瘤患者来源的异种移植瘤生长停滞并降低癌细胞干性

Marayati, Raoud; Bownes, Laura V; Quinn, Colin H; Wadhwani, Nikita; Williams, Adele P; Markert, Hooper R; Atigadda, Venkatram; Aye, Jamie M; Stewart, Jerry E; Yoon, Karina J; Beierle, Elizabeth A

Socioeconomic disparities affect survival in malignant ovarian germ cell tumors in AYA population

社会经济差异会影响青少年及青年人群中恶性卵巢生殖细胞肿瘤的生存率

Bownes, Laura V; Stafman, Laura L; Maizlin, Ilan I; Dellinger, Matthew; Gow, Kenneth W; Goldin, Adam B; Goldfarb, Melanie; Langer, Monica; Raval, Mehul V; Doski, John J; Nuchtern, Jed G; Vasudevan, Sanjeev A; Beierle, Elizabeth A